NO992468D0 - Sammensetning for behandling av gastrointestinale forstyrrelser inneholdende vismut og NSAID - Google Patents

Sammensetning for behandling av gastrointestinale forstyrrelser inneholdende vismut og NSAID

Info

Publication number
NO992468D0
NO992468D0 NO992468A NO992468A NO992468D0 NO 992468 D0 NO992468 D0 NO 992468D0 NO 992468 A NO992468 A NO 992468A NO 992468 A NO992468 A NO 992468A NO 992468 D0 NO992468 D0 NO 992468D0
Authority
NO
Norway
Prior art keywords
nsaids
treatment
composition
gastrointestinal disorders
containing bismuth
Prior art date
Application number
NO992468A
Other languages
English (en)
Other versions
NO992468L (no
Inventor
Jonathan Davidson Kaunitz
Owen Rickford Carryl
Shin Tanaka
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO992468D0 publication Critical patent/NO992468D0/no
Publication of NO992468L publication Critical patent/NO992468L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/245Bismuth; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO992468A 1996-11-22 1999-05-21 Sammensetning for behandling av gastrointestinale forstyrrelser inneholdende vismut og NSAID NO992468L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75551796A 1996-11-22 1996-11-22
PCT/US1997/021462 WO1998022118A1 (en) 1996-11-22 1997-11-21 Compositions for the treatment of gastrointestinal disorders containing bismuth and nsaid

Publications (2)

Publication Number Publication Date
NO992468D0 true NO992468D0 (no) 1999-05-21
NO992468L NO992468L (no) 1999-07-01

Family

ID=25039481

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992468A NO992468L (no) 1996-11-22 1999-05-21 Sammensetning for behandling av gastrointestinale forstyrrelser inneholdende vismut og NSAID

Country Status (7)

Country Link
EP (1) EP0941102A1 (no)
CN (1) CN1238694A (no)
CA (1) CA2271381A1 (no)
HU (1) HUP9904073A3 (no)
NO (1) NO992468L (no)
TR (1) TR199901101T2 (no)
WO (1) WO1998022118A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
JP2002537336A (ja) * 1999-02-26 2002-11-05 ニトロメド インコーポレーテッド ニトロソ化およびニトロシル化されたプロトンポンプ阻害剤、組成物および使用方法
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
TWI289557B (en) 1999-06-17 2007-11-11 Takeda Chemical Industries Ltd A crystal of a hydrate of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
KR20100002278A (ko) * 2000-12-01 2010-01-06 다케다 야쿠힌 고교 가부시키가이샤 (r)- 또는 (s)-란소프라졸의 결정
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US6514960B1 (en) * 2001-08-27 2003-02-04 Hedonist Biochemical Technologies Co., Ltd. Use of bismuth subgallate in inhibition of production of nitric oxide synthase
CA2493618A1 (en) 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
CA2771725C (en) 2002-10-16 2015-08-18 Takeda Pharmaceutical Company Limited Solid preparation comprising a non-toxic base and a proton pump inhibitor
AU2005264864B2 (en) 2004-06-16 2011-08-11 Takeda Pharmaceutical Company Limited Multiple PPI dosage form
KR101148399B1 (ko) * 2005-06-22 2012-05-23 일양약품주식회사 항궤양제 및 점막보호제를 함유하는 경구용 위장질환치료용 약제 조성물
EA017064B1 (ru) 2008-03-10 2012-09-28 Такеда Фармасьютикал Компани Лимитед Кристаллическое производное бензимидазола
BRPI0918492A2 (pt) 2008-09-09 2015-12-01 Astrazeneca Ab uso de naproxen, ou sal farmaceuticamente aceitável do mesmo, e esomeprazol, ou sal farmaceuticamente aceitável do mesmo
KR20120030106A (ko) 2009-06-25 2012-03-27 아스트라제네카 아베 Nsaid-연관된 궤양의 발생 위험이 있는 환자의 치료 방법
WO2013101897A2 (en) 2011-12-28 2013-07-04 Pozen Inc. Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
WO2023143573A1 (zh) * 2022-01-30 2023-08-03 上海石趣医药科技有限公司 含铋化合物在用于治疗疾病中的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI910088A (fi) * 1990-01-09 1991-07-10 Gist Brocades Nv Oral farmaceutisk komposition.
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions
BR9206796A (pt) * 1991-11-22 1995-05-02 Procter & Gamble Forma de dose unitária de subsalicilato de bismuto
DE69228738D1 (de) * 1991-12-06 1999-04-29 Glaxo Group Ltd Zusammensetzungen zur Behandlung von entzündlichen Zuständen oder Analgesie, die Ranitidin Wismuth Citrat und einen NSAID enthalten

Also Published As

Publication number Publication date
EP0941102A1 (en) 1999-09-15
WO1998022118A1 (en) 1998-05-28
CN1238694A (zh) 1999-12-15
TR199901101T2 (xx) 1999-07-21
NO992468L (no) 1999-07-01
CA2271381A1 (en) 1998-05-28
HUP9904073A2 (hu) 2000-03-28
HUP9904073A3 (en) 2000-04-28

Similar Documents

Publication Publication Date Title
NO992468D0 (no) Sammensetning for behandling av gastrointestinale forstyrrelser inneholdende vismut og NSAID
NO20001754L (no) Prostaglandinagonister og anvendelse derav for behandling av benforstyrrelser
NO20004098L (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
IS5070A (is) Nýtt form S-handhverfu ómeprasóls og lyfjablöndursem innihalda það
NO994778D0 (no) FremgangsmÕter og sammensetninger for behandling av tarmbetennelse
NO982311D0 (no) Sammensetninger og fremgangsmÕter for forhindring og behandling av oral mukositt
NO971236D0 (no) Flytende anordning og fremgangsmåte for fremstilling av anordningen
DE69607321T2 (de) Reinigungsverfahren und zusammensetzung
NO20063000L (no) Kombinasjon og farmasøytisk blanding for behandling av diabetes samt anvendelse derav.
DE69723398T2 (de) Polyalkylphenoxyaminoalkane und diese enthaltende freibstoffzusammensetzungen
LV11865A (lv) Kompozicijas un panemieni tuklo sunu iekaisumu arstesanai
NO20012916D0 (no) Sammensetninger og fremgangsmåter for behandling av anorektale forstyrrelser
DE69718863D1 (de) Aufzeichnungsgerät und Videokamera
DK0804078T3 (da) Sammensætning og anvendelse deraf
NO992469D0 (no) Sammensetninger inneholdende vismut og NSAID samt ett eller fler anti-mikrobielle midler til behandling av gastrointestinale lidelser
NO982265D0 (no) Diagnostikk for og mediatoter for inflammatoriske forstyrrelser
DE69724629D1 (de) Zusammensetzungen und deren verwendungen
NO20012963L (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
NO20004274D0 (no) Proteaseaktivert reseptor 4 og anvendelse derav
NO983512D0 (no) Midler for behandling og forhindring av AIDS
NO961226L (no) Blandinger for forebyggelse og behandling av viralinduserte tumorer
NO20001717D0 (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
DK15997A (da) Indretning til opbevaring af tovværk og tilsvarende
DE69708800T2 (de) Racemische Verbindung und antiferroelektrische Flüssigkristallzusammensetzung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application